NCT00541411Unknown不适用
Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma
适应症
相关药物
试验速览
- 阶段
- 不适用
- 入组人数
- 10
- 主要终点
- Efficacy
研究概览
简要总结
Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide combination chemotherapy in Ewing's Sarcoma
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with Ewing's Sarcoma
排除标准
- 未提供
结局指标
主要结局
Efficacy
时间窗: overall
次要结局
未报告次要终点
研究者
Dr. Naeem A. Chaudhri
Principal Investigator
King Faisal Specialist Hospital & Research Center
相似试验
已完成
3 期
Combination Chemotherapy in Treating Patients With Previously Untreated RhabdomyosarcomaAdult Malignant MesenchymomaAdult RhabdomyosarcomaAlveolar Childhood RhabdomyosarcomaChildhood Malignant MesenchymomaEmbryonal Childhood RhabdomyosarcomaEmbryonal-botryoid Childhood RhabdomyosarcomaNonmetastatic Childhood Soft Tissue SarcomaPreviously Untreated Childhood RhabdomyosarcomaStage I Adult Soft Tissue SarcomaStage II Adult Soft Tissue SarcomaStage III Adult Soft Tissue SarcomaNCT00003958Children's Oncology Group702
已完成
3 期
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed RhabdomyosarcomaRhabdomyosarcomaAdult RhabdomyosarcomaChildhood Botryoid-Type Embryonal RhabdomyosarcomaStage I Adult Soft Tissue Sarcoma AJCC v7Stage III Adult Soft Tissue Sarcoma AJCC v7Localized Childhood Soft Tissue SarcomaChildhood Alveolar RhabdomyosarcomaChildhood Embryonal RhabdomyosarcomaStage II Adult Soft Tissue Sarcoma AJCC v7SarcomaNCT00354835Children's Oncology Group481
招募中
不适用
Phase II study of vincristine, actinomycin-D, cyclophosphamide and irinotecan for patients with newly diagnosed intermediate rhabdomyosarcoma.rhabdomyosarcomaJPRN-UMIN000023956Japan Rhabdomyosarcoma Study Group40
招募中
2 期
Phase II study of vincristine, actinomycin-D, cyclophosphamide and irinotecan for patients with newly diagnosed low-risk subset B rhabdomyosarcoma.rhabdomyosarcomaJPRN-UMIN000017004Japan Rhabdomyosarcoma Study Group18
招募中
2 期
Phase II study of VAC1.2/VI therapy for patients with newly diagnosed low-risk subset B rhabdomyosarcoma.D012208rhabdomyosarcomaJPRN-jRCTs051180200Miyachi Mitsuru18